Home » Topics » BioWorld Science

BioWorld Science
RSS

Organ-on-a-chip bests standard toxicity tests

Jan. 20, 2021

IMPACT Therapeutics identifies ATR kinase inhibitors

Jan. 20, 2021

Shanghai Pharmaceuticals Holding patents Wee1-like protein kinase inhibitors

Jan. 20, 2021

ZM-32, a novel muscone derivative that inhibits breast tumor angiogenesis in vivo

Jan. 20, 2021

New IL-17 modulators discovered at UCB

Jan. 20, 2021

Bayer synthesizes new P2X3 receptor antagonists

Jan. 20, 2021

Ivermectin found useful in patients with nonsevere COVID-19 disease

Jan. 20, 2021

European Commission approves Enhertu for HER2-positive breast cancer

Jan. 20, 2021

FDA clears IND application for TERN-501 to be developed as treatment for NASH

Jan. 20, 2021

First patient dosed in second phase II study of AD-109 in obstructive sleep apnea

Jan. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026